文献速递白血病造血干细胞移植与细胞治疗

儿童急性髓系白血病异基因造血细胞移植后的免疫谱分析

Immune profiling after allogeneic hematopoietic cell transplantation in pediatric acute myeloid leukemia.
PubMed 文献 · Blood Adv · 2023-01-01

研究采用多模态单细胞蛋白基因组学方法,分析4例儿童急性髓系白血病患者诊断时与移植后复发时骨髓样本的免疫特征。结果显示,祖细胞样原始细胞中MHC II类分子表达下调最显著,复发时活化自然杀伤细胞及CD8+ T细胞亚群对干扰素γ、经NF-κB的肿瘤坏死因子α信号及白细胞介素-2/STAT5信号反应丧失,提示功能失调。

要点

  • 移植后复发样本中祖细胞样原始细胞MHC II类分子表达下调最显著。
  • 复发时活化自然杀伤细胞及CD8+ T细胞亚群对干扰素γ、经NF-κB的TNFα及IL-2/STAT5信号反应丧失。
  • 移植后复发样本T细胞克隆分析显示功能失调T细胞扩增及调节性T细胞与辅助性T细胞富集。

核心结论

  • 儿童急性髓系白血病移植后复发呈现多样的免疫相关转录特征,此前未见报道。

研究设计与样本

  • 采用多模态单细胞蛋白基因组学方法,评估4例儿童急性髓系白血病患者诊断时与移植后复发时骨髓样本的免疫特征。

主要发现

  • 祖细胞样原始细胞中MHC II类分子表达下调最显著,并伴有转录调控的相关变化。
  • 复发时活化自然杀伤细胞及CD8+ T细胞亚群功能失调,表现为对干扰素γ、经NF-κB的肿瘤坏死因子α信号及白细胞介素-2/STAT5信号反应丧失。
  • 移植后复发样本T细胞克隆分析显示功能失调T细胞扩增及调节性T细胞与辅助性T细胞富集。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although allogeneic hematopoietic cell transplant (allo-HCT) is curative for high-risk pediatric acute myeloid leukemia (AML), disease relapse remains the primary cause of posttransplant mortality. To identify pressures imposed by allo-HCT on AML cells that escape the graft-versus-leukemia effect, we evaluated immune signatures at diagnosis and posttransplant relapse in bone marrow samples from 4 pediatric patients using a multimodal single-cell proteogenomic approach. Downregulation of major histocompatibility complex class II expression was most profound in progenitor-like blasts and accompanied by correlative changes in transcriptional regulation. Dysfunction of activated natural killer cells and CD8+ T-cell subsets at relapse was evidenced by the loss of response to interferon gamma, tumor necrosis factor α signaling via NF-κB, and interleukin-2/STAT5 signaling. Clonotype analysis of posttransplant relapse samples revealed an expansion of dysfunctional T cells and enrichment of T-regulatory and T-helper cells. Using novel computational methods, our results illustrate a diverse immune-related transcriptional signature in posttransplant relapses not previously reported in pediatric AML.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Shahid S, Ceglia N, Le Luduec JB, et al. Immune profiling after allogeneic hematopoietic cell transplantation in pediatric acute myeloid leukemia. Blood Adv. 2023. PMID: 37327118. doi:10.1182/bloodadvances.2022009468

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。